Clinical Trials Logo

Strabismus clinical trials

View clinical trials related to Strabismus.

Filter by:

NCT ID: NCT04961021 Completed - Strabismus Clinical Trials

Management of Consecutive Exotropia

Start date: August 3, 2020
Phase: N/A
Study type: Interventional

Patients with consecutive exotropia will be managed by medial rectus muscle advancement +/- resection or medial rectus muscle advancement +/- lateral rectus recession

NCT ID: NCT04927468 Not yet recruiting - Clinical trials for Graves Ophthalmopathy

Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate supramaximal rectus recession for strabismus in Grave's Ophthalmopathy

NCT ID: NCT04919694 Not yet recruiting - Clinical trials for Thyroid Associated Ophthalmopathy

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether combination of orbital compression surgery with strabismus surgery is better than strabismus surgery after orbital compression surgery in the treatment of moderate-to-severe thyroid associated ophthalmopathy

NCT ID: NCT04918862 Completed - Clinical trials for 1mg Vs 3 mg of Granisetron

A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA

Start date: January 8, 2021
Phase: Phase 3
Study type: Interventional

Investigators aim to determine the optimal dose of granisetron in strabismus ophthalmic surgeries under general anesthesia to prevent postoperative nausea and vomiting

NCT ID: NCT04859062 Completed - Squint Clinical Trials

Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Assessing the efficacy of lidocaine gel 2% application 10 minutes before surgery on post operative pain and the use of analgesics postoperatively

NCT ID: NCT04837534 Completed - Amblyopia Clinical Trials

Improving the Follow up Rate for Pediatric Patients

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

Follow-up of pediatric patients is important for their regular ocular morbidity monitoring, especially for amblyopia management. An observatory data of 1st week (1st to 7th) of January 2019 revealed that the follow-up compliance was very low (22%) among children aged 0-16 years in the pediatric department of Bharatpur Eye Hospital. A problem tree analysis showed a lack of awareness in children and their parents regarding the importance of follow-up and patients forgetting regarding the follow-up visit, usually when there is the long duration of follow up are the major contributing factors for poor adherence to follow-up. So, an intervention study was aimed at finding the effectiveness of counseling and reminders through SMS and phone calls to improve the follow-ups. All pediatric patients 0-16 years of age with ocular conditions requiring at least 3 follow-ups in the study period (January 2021 to April 2021) will be included. Two hundred and sixty-four participants will be equally distributed to three groups: routine standard care, counseling, and reminders with SMS and phone calls. In the routine care group, children will undergo routine care as per existing practice in the hospital and there will be no additional intervention. In counseling group, in addition to routine care parents/guardians along with the child will receive counseling from a trained counselor as per the set counseling protocol in every follow-up visits and will also be provided with the disease-specific information leaflets as additional information material before the child is discharged from the department. In the SMS and phone call reminder group, in addition to routine care, parents/guardians of children will receive reminders through short messaging text (SMS) 3 days and phone calls one day prior to the scheduled visit. Compliance to follow up Participants completing all the three follow-up visits as per the schedule within the window period of +/-2 days will be considered as a complaint to follow up. However, the follow-ups of all the participants will be recorded although that is beyond the window period. The primary outcome will be measured by the proportion of children completing all three scheduled follow-ups. The ethical approval has been obtained from the Institutional Review Committee of NHRC (ERB protocol registration number 761/2020 P). Informed consent will be taken from parent and child. Conclusion: If interventions improve the follow-up rate and are cost-effective, this can be applied in all the departments of the hospital.

NCT ID: NCT04821817 Recruiting - Strabismus Clinical Trials

Peribulbar Rocuronium in Adult Strabismus Surgery

Start date: April 3, 2021
Phase: N/A
Study type: Interventional

- This is a prospective randomized clinical study that will be carried on adult patients aged from 21-60 years and presented for strabismus surgery under peribulbar anesthesia. - Patients will be excluded if they refused to participate or had a contraindication to peribulbar anesthesia. - Patients will be randomly distributed into either control group in which peribulbar anesthesia will be performed by injection of 10 ml local anesthetic mixture composed of 4 ml of plain bupivacaine 0.5%, 4 ml of lidocaine 2% containing 50 IU, and 2 ml normal saline or rocuronium group which peribulbar anesthesia will be performed by injection of 10 ml local anesthetic mixture composed of 4 ml of plain bupivacaine 0.5%, 4 ml of lidocaine 2% containing 50 IU, and 0.06 mg/kg of rocuronium in 2 ml normal saline. - Measurements will include; - 1. Patient age, weight, height, gestational age, and gravidity. 2. The duration of globe akinesia (primary outcome). 3. The onset of lid and globe akinesia and the duration of lid akinesia 4. The onset and duration of sensory block 5. Time required to start the surgery 6. Akinesia score 7. The visual analog score (VAS) which is composed of 0-10 score will be used to assess the severity of postoperative pain (where 0=no pain and 10=severe pain), The VAS score will be evaluated 1 h, 2 h postoperative, then every 2 h till 12 h. Any patients with VAS score more than 4 received rescue analgesia in the form of 50 mg tramadol intravenous injection with the calculation of the time for the first call of postoperative analgesia. 8. Any detected complication as nausea and vomiting, pain on injection, or increased intraocular tension.

NCT ID: NCT04782960 Not yet recruiting - Anesthesia, Local Clinical Trials

Subconjunctival Bupivacaine in Strabismus Surgery

Start date: April 2021
Phase: N/A
Study type: Interventional

This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.

NCT ID: NCT04770519 Recruiting - Strabismus Clinical Trials

Genetic Studies of Strabismus, Nystagmus, and Associated Disorders

Start date: September 3, 2021
Phase:
Study type: Observational

Strabismus (misalignment of the eyes) often runs in families. In this study, the investigators are looking for genetic variants associated with strabismus and nystagmus. Three types of subects will be enrolled: (1) Families with at least 3 members with strabismus, (2) individuals with infantile esotropia and their parents and siblings, and (3) individuals with infantile nystagmus and their parents. Whole exome and/or whole genome sequencing will be used to identify genetic variants shared by family members with strabismus and to identify genetic causes of nystagmus.

NCT ID: NCT04617158 Completed - Clinical trials for Strabismus, Comitant

Comparing Adjustable Sutures Surgery

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

Adjustable suture surgery will be done in patients with horizontal strabismus comparing the time of adjustment